Moreover, incremental expression of CCAT1 and CCAT2 might enable aggressive growth and intrusion of CRC cells [13, 14], and lncRNA MIR100HG was able to reinforce cetuximab-tolerance of CRC cells via activation of Wnt/β-catenin signaling [15]. This evidence concerns the gene CCAT2 and colorectal carcinoma.